These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

546 related items for PubMed ID: 30421493

  • 1. CD147 promotes progression of head and neck squamous cell carcinoma via NF-kappa B signaling.
    Yu B, Zhang Y, Wu K, Wang L, Jiang Y, Chen W, Yan M.
    J Cell Mol Med; 2019 Feb; 23(2):954-966. PubMed ID: 30421493
    [Abstract] [Full Text] [Related]

  • 2. miR-22 regulates cell invasion, migration and proliferation in vitro through inhibiting CD147 expression in tongue squamous cell carcinoma.
    Qiu K, Huang Z, Huang Z, He Z, You S.
    Arch Oral Biol; 2016 Jun; 66():92-7. PubMed ID: 26943814
    [Abstract] [Full Text] [Related]

  • 3. UBE2C promotes the progression of head and neck squamous cell carcinoma.
    Jin Z, Zhao X, Cui L, Xu X, Zhao Y, Younai F, Messadi D, Hu S.
    Biochem Biophys Res Commun; 2020 Mar 05; 523(2):389-397. PubMed ID: 31870550
    [Abstract] [Full Text] [Related]

  • 4. c-MYC-directed NRF2 drives malignant progression of head and neck cancer via glucose-6-phosphate dehydrogenase and transketolase activation.
    Tang YC, Hsiao JR, Jiang SS, Chang JY, Chu PY, Liu KJ, Fang HL, Lin LM, Chen HH, Huang YW, Chen YT, Tsai FY, Lin SF, Chuang YJ, Kuo CC.
    Theranostics; 2021 Mar 05; 11(11):5232-5247. PubMed ID: 33859744
    [Abstract] [Full Text] [Related]

  • 5. Specificity protein 1/microRNA-92b forms a feedback loop promoting the migration and invasion of head and neck squamous cell carcinoma.
    Pang P, Fang H, Wu H, Wang S, Liu M, Jin S, Qi Z, Li Z, Liu F, Sun C.
    Bioengineered; 2021 Dec 05; 12(2):11397-11409. PubMed ID: 34905435
    [Abstract] [Full Text] [Related]

  • 6. Lactate secreted by PKM2 upregulation promotes Galectin-9-mediated immunosuppression via inhibiting NF-κB pathway in HNSCC.
    Chang H, Xu Q, Li J, Li M, Zhang Z, Ma H, Yang X.
    Cell Death Dis; 2021 Jul 21; 12(8):725. PubMed ID: 34290225
    [Abstract] [Full Text] [Related]

  • 7. LASP1 promotes proliferation, metastasis, invasion in head and neck squamous cell carcinoma and through direct interaction with HSPA1A.
    Chen Q, Wu K, Qin X, Yu Y, Wang X, Wei K.
    J Cell Mol Med; 2020 Jan 21; 24(2):1626-1639. PubMed ID: 31793711
    [Abstract] [Full Text] [Related]

  • 8. Downregulation of LINC00460 decreases STC2 and promotes autophagy of head and neck squamous cell carcinoma by up-regulating microRNA-206.
    Xue K, Li J, Nan S, Zhao X, Xu C.
    Life Sci; 2019 Aug 15; 231():116459. PubMed ID: 31075234
    [Abstract] [Full Text] [Related]

  • 9. Xenotropic and polytropic retrovirus receptor 1 (XPR1) promotes progression of tongue squamous cell carcinoma (TSCC) via activation of NF-κB signaling.
    Chen WC, Li QL, Pan Q, Zhang HY, Fu XY, Yao F, Wang JN, Yang AK.
    J Exp Clin Cancer Res; 2019 Apr 17; 38(1):167. PubMed ID: 30995931
    [Abstract] [Full Text] [Related]

  • 10. ELOVL6 promotes the progression of head and neck squamous cell carcinoma via activating WNT/β-catenin pathway.
    Wang R, Liu X, Li X, Qian M, Yang X, Jiang Q, Wang Y, Liu H, Chen J, Wang X, Gong L.
    Mol Carcinog; 2024 Jun 17; 63(6):1079-1091. PubMed ID: 38426809
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A Study on the Correlations of the miR-31 Expression with the Pathogenesis and Prognosis of Head and Neck Squamous Cell Carcinoma.
    Qiang H, Zhan X, Wang W, Cheng Z, Ma S, Jiang C.
    Cancer Biother Radiopharm; 2019 Apr 17; 34(3):189-195. PubMed ID: 30628842
    [Abstract] [Full Text] [Related]

  • 15. P4HA2 contributes to head and neck squamous cell carcinoma progression and EMT through PI3K/AKT signaling pathway.
    Wu YL, Liu W, Zhao T, Jin J.
    Med Oncol; 2024 May 23; 41(6):163. PubMed ID: 38777998
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. High expression of ACTL8 is poor prognosis and accelerates cell progression in head and neck squamous cell carcinoma.
    Li B, Zhu J, Meng L.
    Mol Med Rep; 2019 Feb 23; 19(2):877-884. PubMed ID: 30535476
    [Abstract] [Full Text] [Related]

  • 18. G-Protein-Coupled Receptor Kinase-Interacting Protein 1 (GIT1) Promotes Head and Neck Squamous Cell Carcinoma Metastases via Activating the PI3K/AKT/mTOR Signal Pathway.
    Xu R, Xu R, Wang Y, Wang W, Jiang L, Gong S.
    Comput Math Methods Med; 2022 Feb 23; 2022():6881932. PubMed ID: 35116073
    [Abstract] [Full Text] [Related]

  • 19. ETV5 facilitates tumor progression in head-neck squamous cell carcinoma.
    Yu S, Ma Z, Chen T, Wang H, Yao Q, Li J, Cheng J.
    Oral Dis; 2024 May 23; 30(4):2004-2017. PubMed ID: 37649213
    [Abstract] [Full Text] [Related]

  • 20. SFRP1 mediates cancer-associated fibroblasts to suppress cancer cell proliferation and migration in head and neck squamous cell carcinoma.
    Dong L, Li Y, Song X, Sun C, Song X.
    BMC Cancer; 2024 Sep 19; 24(1):1165. PubMed ID: 39300373
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.